Discovery of a Highly Selective Glycogen Synthase Kinase-3 Inhibitor (PF-04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET Neuroimaging

被引:69
作者
Liang, Steven H. [1 ,2 ]
Chen, Jinshan Michael [3 ]
Normandin, Marc D. [1 ,2 ]
Chang, Jeanne S. [3 ]
Chang, George C. [3 ]
Taylor, Christine K. [3 ]
Trapa, Patrick [4 ]
Plummer, Mark S. [3 ]
Para, Kimberly S. [3 ]
Conn, Edward L. [3 ]
Lopresti-Morrow, Lori [3 ]
Lanyon, Lorraine F. [3 ]
Cook, James M. [3 ]
Richter, Karl E. G. [3 ]
Nolan, Charlie E. [3 ]
Schachter, Joel B. [3 ]
Janat, Fouad [3 ]
Che, Ye [3 ]
Shanmugasundaram, Veerabahu [3 ]
Lefker, Bruce A. [4 ]
Enerson, Bradley E. [3 ]
Livni, Elijahu [1 ,2 ]
Wang, Lu [1 ,2 ]
Guehl, Nicolas J. [1 ,2 ]
Patnaik, Debasis [6 ,7 ]
Wagner, Florence F. [5 ]
Perlis, Roy [5 ,6 ,7 ]
Holson, Edward B. [5 ]
Haggarty, Stephen J. [6 ,7 ]
El Fakhri, Georges [1 ,2 ]
Kurumbail, Ravi G. [3 ]
Vasdev, Neil [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Gordon Ctr Med Imaging & Nucl Med & Mol Imaging, Boston, MA 02114 USA
[2] Harvard Med Sch, Dept Radiol, Boston, MA 02114 USA
[3] Pfizer Worldwide Res & Dev, Groton Labs, Eastern Point Rd, Groton, CT 06340 USA
[4] Pfizer Worldwide Res & Dev, 610 Main St, Cambridge, MA 02139 USA
[5] Broad Inst, Stanley Ctr Psychiat Res, 415 Main St, Cambridge, MA 02142 USA
[6] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, 185 Cambridge St, Boston, MA 02114 USA
[7] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, 185 Cambridge St, Boston, MA 02114 USA
关键词
Alzheimer's disease; glycogen synthase kinase-3; phosphorylation; positron emission tomography; tau proteins; ALZHEIMERS-DISEASE; TRANSGENIC MICE; GSK-3-BETA; RADIOSYNTHESIS; RADIOTRACER; VIVO;
D O I
10.1002/anie.201603797
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Glycogen synthase kinase-3 (GSK-3) regulates multiple cellular processes in diabetes, oncology, and neurology. N-(3-(1H-1,2,4-triazol-1-yl)propyl)-5-(3-chloro-4-methoxyphenyl)oxazole-4-carboxamide (PF-04802367 or PF367) has been identified as a highly potent inhibitor, which is among the most selective antagonists of GSK-3 to date. Its efficacy was demonstrated in modulation of tau phosphorylation in vitro and in vivo. Whereas the kinetics of PF-367 binding in brain tissues are too fast for an effective therapeutic agent, the pharmacokinetic profile of PF-367 is ideal for discovery of radiopharmaceuticals for GSK-3 in the central nervous system. A C-11-isotopologue of PF-367 was synthesized and preliminary PET imaging studies in non-human primates confirmed that we have overcome the two major obstacles for imaging GSK-3, namely, reasonable brain permeability and displaceable binding.
引用
收藏
页码:9601 / 9605
页数:5
相关论文
共 41 条
[1]   Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors [J].
Luo, Guanglin ;
Chen, Ling ;
Burton, Catherine R. ;
Xiao, Hong ;
Sivaprakasam, Prasanna ;
Krause, Carol M. ;
Cao, Yang ;
Liu, Nengyin ;
Lippy, Jonathan ;
Clarke, Wendy J. ;
Snow, Kimberly ;
Raybon, Joseph ;
Arora, Vinod ;
Pokross, Matt ;
Kish, Kevin ;
Lewis, Hal A. ;
Langley, David R. ;
Macor, John E. ;
Dubowchik, Gene M. .
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (03) :1041-1051
[2]   Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3 beta transgenes [J].
Brownlees, J ;
Irving, NG ;
Brion, JP ;
Gibb, BJM ;
Wagner, U ;
Woodgett, J ;
Miller, CCJ .
NEUROREPORT, 1997, 8 (15) :3251-3255
[3]   Glycogen Synthase Kinase-3β2 Has Lower Phosphorylation Activity to Tau than Glycogen Synthase Kinase-3β1 [J].
Saeki, Kazunori ;
Machida, Mayumi ;
Kinoshita, Yutaro ;
Takasawa, Ryoko ;
Tanuma, Sei-ichi .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (01) :146-149
[4]   Identification of a novel selective and potent inhibitor of glycogen synthase kinase-3 [J].
Noori, Mahboubeh S. ;
Bhatt, Pooja M. ;
Courreges, Maria C. ;
Ghazanfari, Davoud ;
Cuckler, Chaz ;
Orac, Crina M. ;
McMills, Mark C. ;
Schwartz, Frank L. ;
Deosarkar, Sudhir P. ;
Bergmeier, Stephen C. ;
McCall, Kelly D. ;
Goetz, Douglas J. .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2019, 317 (06) :C1289-C1303
[5]   Glycogen synthase kinase-3β-mediated tau phosphorylation in cultured cell lines [J].
Lee, CWC ;
Lau, KF ;
Miller, CCJ ;
Shaw, PC .
NEUROREPORT, 2003, 14 (02) :257-260
[6]   Selective loss of glycogen synthase kinase-3α in birds reveals distinct roles for GSK-3 isozymes in tau phosphorylation [J].
Alon, Lina Tsaadon ;
Pietrokovski, Shmuel ;
Barkan, Shay ;
Avrahami, Limor ;
Kaidanovich-Beilin, Oksana ;
Woodgett, James R. ;
Barnea, Anat ;
Eldar-Finkelman, Hagit .
FEBS LETTERS, 2011, 585 (08) :1158-1162
[7]   Tau phosphorylation by glycogen synthase kinase 3β modulates enzyme acetylcholinesterase expression [J].
Cortes-Gomez, Maria-Angeles ;
Llorens-Alvarez, Esther ;
Alom, Jordi ;
del Ser, Teodoro ;
Avila, Jesus ;
Saez-Valero, Javier ;
Garcia-Ayllon, Maria-Salud .
JOURNAL OF NEUROCHEMISTRY, 2021, 157 (06) :2091-2105
[8]   Exposure to Pyrithiamine Increases β-Amyloid Accumulation, Tau Hyperphosphorylation, and Glycogen Synthase Kinase-3 Activity in the Brain [J].
Zhao, Jing ;
Sun, Xiaojing ;
Yu, Zhe ;
Pan, Xiaoli ;
Gu, Fenghua ;
Chen, Jia ;
Dong, Wenxin ;
Zhao, Lei ;
Zhong, Chunjiu .
NEUROTOXICITY RESEARCH, 2011, 19 (04) :575-583
[9]   Leptin inhibits glycogen synthase kinase-3β to prevent tau phosphorylation in neuronal cells [J].
Greco, Steven J. ;
Sarkar, Sraboni ;
Casadesus, Gemma ;
Zhu, Xiongwei ;
Smith, Mark A. ;
Ashford, J. Wesson ;
Johnston, Jane M. ;
Tezapsidis, Nikolaos .
NEUROSCIENCE LETTERS, 2009, 455 (03) :191-194
[10]   Glycogen Synthase Kinase-3 Regulates Production of Amyloid-β Peptides and Tau Phosphorylation in Diabetic Rat Brain [J].
Qu, Zhong-Sen ;
Li, Liang ;
Sun, Xiao-Jiang ;
Zhao, Yu-Wu ;
Zhang, Jin ;
Geng, Zhi ;
Fu, Jian-Liang ;
Ren, Qing-Guo .
SCIENTIFIC WORLD JOURNAL, 2014,